These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8137621)

  • 1. Carcinoma of the esophagus: an overview.
    Harvey JC; Beattie EJ
    Compr Ther; 1994; 20(1):55-60. PubMed ID: 8137621
    [No Abstract]   [Full Text] [Related]  

  • 2. Claim for screening endoscopy of the esophagus.
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Oct; 104(10):2632-3; author reply 2633. PubMed ID: 19806097
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma.
    Rubenstein JH; Inadomi JM
    Am J Gastroenterol; 2009 Dec; 104(12):3106-7; author reply 3107-8. PubMed ID: 19956133
    [No Abstract]   [Full Text] [Related]  

  • 4. Current management of carcinoma of the esophagus.
    Ellis FH
    Compr Ther; 1993; 19(5):214-9. PubMed ID: 7506132
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Section I: epidemiological review.
    Lukanich JM
    Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):158-66. PubMed ID: 12838486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States.
    Kubo A; Corley DA
    Cancer; 2002 Nov; 95(10):2096-102. PubMed ID: 12412162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.
    Cooper GS; Kou TD; Chak A
    Am J Gastroenterol; 2009 Jun; 104(6):1356-62. PubMed ID: 19491849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rising incidence of esophageal adenocarcinoma.
    Sharma P; Sampliner RE
    Adv Intern Med; 2001; 46():137-53. PubMed ID: 11147251
    [No Abstract]   [Full Text] [Related]  

  • 10. Endoscopic surveillance of Barrett's esophagus: another viewpoint.
    Richter JE
    Am J Gastroenterol; 1993 May; 88(5):630-2. PubMed ID: 8480722
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.
    Pohl H; Welch HG
    J Natl Cancer Inst; 2005 Jan; 97(2):142-6. PubMed ID: 15657344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing epidemiology of esophageal adenocarcinoma.
    Wei JT; Shaheen N
    Semin Gastrointest Dis; 2003 Jul; 14(3):112-27. PubMed ID: 14653411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Carbonated soft drink consumption and risk of esophageal adenocarcinoma.
    Gallus S; Talamini R; Fernandez E; Dal Maso L; Franceschi S; La Vecchia C
    J Natl Cancer Inst; 2006 May; 98(9):645-6; author reply 646-7. PubMed ID: 16670393
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the treatment of esophageal carcinoma.
    Rice TW; Adelstein DJ; Zuccaro G; Falk GW; Goldblum JR
    Gastroenterologist; 1997 Dec; 5(4):278-94. PubMed ID: 9436004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal surgery and gastroenterology. III. Diagnosis and treatment of esophageal carcinoma].
    Siersema PD; van Lanschot JJ; Fockens P; Tilanus HW
    Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1947-52. PubMed ID: 10526613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal carcinoma.
    Tytgat KM; Tytgat GN
    Hepatogastroenterology; 1990 Aug; 37(4):353-7. PubMed ID: 1698697
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States.
    Kubo A; Corley DA
    Am J Gastroenterol; 2004 Apr; 99(4):582-8. PubMed ID: 15089886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal cancer. Clinical and pathologic features.
    Gore RM
    Radiol Clin North Am; 1997 Mar; 35(2):243-63. PubMed ID: 9087202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.